Skip to main content
Log in

Structure and Alternative Splicing of the Antisense FMR1 (ASFMR1) Gene

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by an expansion of 55–200 CGG repeats (premutation) in the 5'-UTR of the FMR1 gene. Bidirectional transcription at FMR1 locus has been demonstrated and specific alternative splicing of the Antisense FMR1 (ASFMR1) gene has been proposed to have a contributing role in the pathogenesis of FXTAS. The structure of ASFMR1 gene is still uncharacterized and it is currently unknown how many isoforms of the gene are expressed and at what level in premutation carriers (PM) and if they may contribute to the premutation pathology. In this study, we characterized the ASFMR1 gene structure and the transcriptional landscape by using PacBio SMRT sequencing with target enrichment (IDT customized probe panel). We identified 45 ASFMR1 isoforms ranging in sizes from 523 bp to 6 Kb, spanning approximately 59 kb of genomic DNA. Multiplexing and sequencing of six human brain samples from PM samples and normal control (HC) were carried out on the PacBio Sequel platform. We validated the presence of these isoforms by qRT-PCR and Sanger sequencing and characterized the acceptor and donor splicing site consensus sequences. Consistent with previous studies conducted in other tissue types, we found a high expression of ASFMR1 isoform Iso131bp in brain samples of PM as compared to HC, while no differences in expression levels were observed for the newly identified isoforms IsoAS1 and IsoAS2. We investigated the role of the splicing regulatory protein Sam68 which we did not observe in the alternative splicing of the ASFMR1 gene. Our study provides a useful insight into the structure of ASFMR1 gene and transcriptional landscape along with the expression pattern of various newly identified novel isoforms and on their potential role in premutation pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4 
Fig. 5 

Similar content being viewed by others

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Hagerman RJ, Leehey M, Heinrichs W et al (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127–130

    Article  CAS  PubMed  Google Scholar 

  2. Mila M, Alvarez-Mora MI, Madrigal I, Rodriguez-Revenga L (2018) Fragile X syndrome: an overview and update of the FMR1 gene. Clin Genet 93:197–205

    Article  CAS  PubMed  Google Scholar 

  3. Sellier C, Rau F, Liu Y et al (2010) Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 29:1248–1261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tassone F, Hagerman RJ, Taylor AK et al (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the Fragile-X syndrome. Am J Human Genet 66:6–15

    Article  CAS  Google Scholar 

  5. Hagerman RJ, Hagerman P (2016) Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol 12:403–412

    Article  CAS  PubMed  Google Scholar 

  6. Su C-H, Dhananjaya D, Tarn W-Y (2018) Alternative splicing in neurogenesis and brain development. Front Mol Biosci 5:12

    Article  PubMed  PubMed Central  Google Scholar 

  7. Paronetto MP, Passacantilli I, Sette C (2016) Alternative splicing and cell survival: from tissue homeostasis to disease. Cell Death Differ 23:1919–1929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Quesnel-Vallières M, Dargaei Z, Irimia M et al (2016) Misregulation of an activity-dependent splicing network as a common mechanism underlying autism spectrum disorders. Mol Cell 64:1023–1034

    Article  PubMed  Google Scholar 

  9. Koch L (2018) Altered splicing in Alzheimer transcriptomes. Nat Rev Genet 19:738–739

    Article  CAS  PubMed  Google Scholar 

  10. Pretto DI, Eid JS, Yrigollen CM et al (2015) Differential increases of specific FMR1 mRNA isoforms in premutation carriers. J Med Genet 52:42–52

    Article  CAS  PubMed  Google Scholar 

  11. Tseng E, Tang H-T, AlOlaby RR et al (2017) Altered expression of the FMR1 splicing variants landscape in premutation carriers. Biochim Biophys Acta Gene Regul Mech 1860:1117–1126

    Article  CAS  PubMed  Google Scholar 

  12. Zafarullah M, Tang H-T, Durbin-Johnson B et al (2020) FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS). Sci Rep 10:11099

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Khalil AM, Faghihi MA, Modarresi F et al (2008) A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One 3:e1486

    Article  PubMed  PubMed Central  Google Scholar 

  14. Pastori C, Peschansky VJ, Barbouth D et al (2014) Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome. Hum Genet 133:59–67

    Article  CAS  PubMed  Google Scholar 

  15. Ladd PD, Smith LE, Rabaia NA et al (2007) An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet 16:3174–3187

    Article  CAS  PubMed  Google Scholar 

  16. Al Olaby RR, Tang H-T, Durbin-Johnson B et al (2018) Assessment of molecular measures in non-FXTAS male premutation carriers. Front Genet 9:302

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vittal P, Pandya S, Sharp K et al (2018) splice variant: a predictor of fragile X-associated tremor/ataxia syndrome. Neurol Genet 4:e246

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Loesch DZ, Godler DE, Evans A et al (2011) Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genet Med 13:392–399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tseng E, Rowell WJ, Glenn O-C et al (2019) The landscape of SNCA transcripts across synucleinopathies: new insights from long reads sequencing analysis. Front Genet 10:584

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sheynkman GM, Tuttle KS, Laval F et al (2020) ORF Capture-Seq as a versatile method for targeted identification of full-length isoforms. Nat Commun 11:2326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Pretto DI, Mendoza-Morales G, Lo J et al (2014) CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet 51:309–318

    Article  CAS  PubMed  Google Scholar 

  22. Tassone F, Pan R, Amiri K et al (2008) A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 10:43–49

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Filipovic-Sadic S, Sah S, Chen L et al (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56:399–408

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Edgar RC (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792–1797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ (2000) Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 97:195–203

    Article  CAS  PubMed  Google Scholar 

  26. Castro AF, Loureiro JR, Bessa J, Silveira I (2020) Antisense transcription across nucleotide repeat expansions in neurodegenerative and neuromuscular diseases: progress and mysteries. Genes 11:1418. https://doi.org/10.3390/genes11121418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Verkerk AJ, Pieretti M, Sutcliffe JS et al (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905–914

    Article  CAS  PubMed  Google Scholar 

  28. Hinds HL, Ashley CT, Sutcliffe JS et al (1993) Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3:36–43

    Article  CAS  PubMed  Google Scholar 

  29. Sánchez-Jiménez F, Sánchez-Margalet V (2013) Role of Sam68 in post-transcriptional gene regulation. Int J Mol Sci 14:23402–23419

    Article  PubMed  PubMed Central  Google Scholar 

  30. Frisone P, Pradella D, Di Matteo A et al (2015) SAM68: signal transduction and RNA metabolism in human cancer. Biomed Res Int 2015:528954

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the participants of the community‐based studies who donated their time and sample for this study. This paper is dedicated to the memory of Matteo.

Funding

This work was supported by the NIH grants RO1HD036071 and RO1MH07804.

Author information

Authors and Affiliations

Authors

Contributions

Designed Research.

Conception: F. Tassone

Organization: M. Zafarullah, and F. Tassone

Execution: M. Zafarullah, F. Tassone

Analyzed Data

Design: F. Tassone, E. Tseng

Execution: J.LI, E. Tseng,

Review and Critique: M. Zafarullah, J. Li, E. Tseng, F. Tassone

Manuscript Preparation

Writing the first draft: M. Zafarullah

Review and Critique: M. Zafarullah, J. Li, E. Tseng, F. Tassone

All authors read and approved the final manuscript.

Corresponding author

Correspondence to Flora Tassone.

Ethics declarations

Ethics Approval

All samples were collected under approved Institutional Review Board (IRB) protocols and all methods were carried out in accordance with the relevant guidelines and regulations.

Consent to Participate

Informed consent was obtained from all individual participants included in the study.

Consent for Publication

Not applicable.

Competing Interests

M.Z.: No disclosures to report.

J.L.: No disclosures to report.

E.T: E.T. is an employee of Pacific Biosciences.

F.T. has received the funding from Azrieli Foundation and Zynerba for studies in Fragile X syndrome.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 18 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zafarullah, M., Li, J., Tseng, E. et al. Structure and Alternative Splicing of the Antisense FMR1 (ASFMR1) Gene. Mol Neurobiol 60, 2051–2061 (2023). https://doi.org/10.1007/s12035-022-03176-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-022-03176-9

Keywords

Navigation